Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hypertension, Portal × Liver Transplantation × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 PRETEXT I Hepatoblastoma 1 Neoplasm Metastasis 1 Hypertension, Portal 1 Fibrosis 1 Carcinoma, Hepatocellular 1

Interventions

tremelimumab 1 durvalumab 1 Liver Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05027425 2024-11-22

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

University of Cincinnati

Phase 2 Active not recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡